| http://www.w3.org/ns/prov#value | - While under myelosuppressive (chemo-)therapy, growth factors, such as G-CSF, should be given according to the guidelines of the American Society of Clinical Oncology.71 The use of G-CSF also might benefit patients who experience prolonged cytopenias after treatment with alemtuzumab.
|
